On December 23, 2020 Ziopharm Oncology, Inc. ("Ziopharm" or "the Company") (Nasdaq: ZIOP), reported that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in a fireside chat at the H.C. Wainwright Bioconnect 2021 Conference and will deliver a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference (Press release, Ziopharm, DEC 23, 2020, View Source [SID1234573226]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Bioconnect 2021 Conference
Date: Monday, January 11, 2021
Time: 6:00 am ET (access to on demand webcast begins)

39th Annual J.P. Morgan Healthcare Conference
Date: Thursday, January 14, 2021
Time: 8:20 am ET
To access the webcast presentations, or the subsequent archived recordings, please visit the "Investors" section of the Ziopharm website at www.ziopharm.com.